glp-1 inventor In an interview with El Médico Interactivo, a Medscape Network platform, Rockefeller researcher Svetlana Mojsov reflects on how her discovery of GLP- 1 has helped millions of people manage their diabetes and obesity This Founder Built Natural GLP-1

Changes in the makeup of bariatric surgery: a national increase in use of laparoscopic sleeve gastrectomy

MEDVi, LLC operates a U.S.-based telehealth platform focused on facilitating access to compounded semaglutide for weight loss

Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: evidence and controversies

Long-term remote organ consequences following acute kidney injury

We found that the rate of thyroid cancer was lower in the patients prescribed GLP-1 medications, but the decrease was only statistically significant in the patients with a BMI between 30 and 35, or class 1 obesity, as shown in Figure 2

B 11 (25), 56685692